Guillaume Canaud

1 Patent

• US124271412025

  BYL719 (alpelisib) for Use in the Treatment of Pik3ca-related Overgrowth Spectrum (PROS-CLOVES Syndrome)

  ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS (APHP)

  0 cites